Skip to content
healthcare.dev

Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension

NDC 64980-448, neomycin and polymyxin B sulfates and hydrocortisone otic, suspension, from Rising Pharma Holdings, Inc..

Product NDC
64980-448
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
SUSPENSION
Route
AURICULAR (OTIC)
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA060613
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64980-448 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROCORTISONE10 mg/mL
  • NEOMYCIN SULFATE3.5 mg/mL
  • POLYMYXIN B SULFATE10000 [USP'U]/mL

Pharmacologic classes

Aminoglycoside Antibacterial [EPC]; Aminoglycosides [CS]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Polymyxin-class Antibacterial [EPC]; Polymyxins [CS]

Package NDCNDC-11Package
64980-448-01649800448011 BOTTLE in 1 CARTON (64980-448-01) / 10 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/35768adc-b578-4c2e-b461-22de3135a789
  • NADAC price for package 64980044801

    GET /v1/drugs/nadac/64980044801

Use it

Look up 64980-448 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64980-448 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64980-448. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.